Physician profile
Thomas R Mccarty
NPI 1376955047
$34,403.82
in general payments reported to CMS, 2019-2025
30 companies · $1,738 in 2025
The $1,738 reported for 2025 was more than what 76% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,017 · 2020: $43.00 · 2021: $13K · 2022: $14K · 2023: $1,212 · 2024: $3,471 · 2025: $1,738.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,222 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,221.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $26,572.70 | 2019-2025 | Orbera Intragastric Balloon System, Agile Esophageal, Exalt Model D |
| Medtronic, INC. | $2,477.31 | 2022-2025 | Beacon, Dragonfly Pancreaticobiliary Scope and Instrument Channel Caps |
| Fujifilm Healthcare Americas Corporation | $892.66 | 2022-2025 | Fujifilm |
| Olympus Corporation of The Americas | $698.78 | 2022 | |
| Abbvie INC. | $542.30 | 2023-2025 | |
| Apollo Endosurgery US INC | $438.42 | 2021-2023 | Overstitch Endoscopic Suturing System |
| Takeda Pharmaceuticals U.S.A., INC. | $404.06 | 2023-2025 | Entyvio, Eohilia, Gattex |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $259.67 | 2022-2025 | Xifaxan, Trulance |
| Janssen Biotech, INC. | $250.78 | 2023-2025 | Tremfya, Stelara |
| Celltrion USA INC. | $236.37 | 2024-2025 | Vegzelma |
| Olympus America INC. | $187.62 | 2022-2025 | Single Use Electrosurgical Knife Kd-655, Single Use Aspiration Needle Na-U200h, Endoclot Phs |
| Cook Medical LLC | $181.98 | 2022-2025 | Hemospray |
| Creo Medical INC. | $178.27 | 2021-2022 | |
| Genzyme Corporation | $133.90 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $119.48 | 2023-2025 | Dupixent |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Steris Corporation | $92.23 | 2025 | |
| Novo Nordisk INC | $84.70 | 2022 | |
| Lilly USA, LLC | $78.50 | 2024-2025 | Omvoh |
| Aimmune Therapeutics, INC. | $76.58 | 2024-2025 | Zenpep |
| Ovesco Endoscopy USA, INC. | $74.75 | 2025 | |
| 3-D Matrix, INC. | $73.17 | 2024 | |
| Phathom Pharmaceuticals, INC. | $71.37 | 2024 | Voquezna |
| Merck Sharp & Dohme LLC | $64.65 | 2023-2024 | Dificid |
| Lumendi LLC | $43.00 | 2020 | |
| Pharmacosmos Therapeutics INC. | $39.09 | 2023 | Monoferric |
| Braintree Laboratories, INC. | $33.77 | 2024 | Suflave, Sutab |
| Ambu INC. | $27.27 | 2025 | |
| Sandoz INC. | $24.91 | 2024 | Hyrimoz |
| Alcresta Therapeutics, INC. | $24.48 | 2023 | Relizorb |
| Csl Behring | $21.05 | 2025 | Kcentra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Mccarty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.